AKYA vs. QSI, AEHR, QTRX, MASS, FEIM, KEQU, NAUT, SEER, RPID, and INTT
Should you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Quantum-Si (QSI), Aehr Test Systems (AEHR), Quanterix (QTRX), 908 Devices (MASS), Frequency Electronics (FEIM), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), Seer (SEER), Rapid Micro Biosystems (RPID), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.
Akoya Biosciences vs.
Quantum-Si (NASDAQ:QSI) and Akoya Biosciences (NASDAQ:AKYA) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.
Akoya Biosciences received 26 more outperform votes than Quantum-Si when rated by MarketBeat users. However, 69.23% of users gave Quantum-Si an outperform vote while only 58.33% of users gave Akoya Biosciences an outperform vote.
Akoya Biosciences has a net margin of -66.77% compared to Quantum-Si's net margin of -3,968.84%. Quantum-Si's return on equity of -36.96% beat Akoya Biosciences' return on equity.
Quantum-Si currently has a consensus target price of $3.48, suggesting a potential upside of 146.45%. Akoya Biosciences has a consensus target price of $3.62, suggesting a potential upside of 134.85%. Given Quantum-Si's stronger consensus rating and higher probable upside, equities analysts plainly believe Quantum-Si is more favorable than Akoya Biosciences.
39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 79.4% of Akoya Biosciences shares are held by institutional investors. 30.0% of Quantum-Si shares are held by company insiders. Comparatively, 7.3% of Akoya Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Quantum-Si has a beta of 2.75, suggesting that its stock price is 175% more volatile than the S&P 500. Comparatively, Akoya Biosciences has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500.
Akoya Biosciences has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, Quantum-Si had 2 more articles in the media than Akoya Biosciences. MarketBeat recorded 8 mentions for Quantum-Si and 6 mentions for Akoya Biosciences. Quantum-Si's average media sentiment score of 0.55 beat Akoya Biosciences' score of -0.22 indicating that Quantum-Si is being referred to more favorably in the media.
Summary
Quantum-Si beats Akoya Biosciences on 11 of the 18 factors compared between the two stocks.
Get Akoya Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Akoya Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:AKYA) was last updated on 3/26/2025 by MarketBeat.com Staff
